Review: Lower urinary tract dysfunction in animal models of Parkinson's disease (PD): Translational aspects for the treatment of PD patients with overactive bladder.

International review of neurobiology Pub Date : 2024-01-01 Epub Date: 2024-01-15 DOI:10.1016/bs.irn.2023.12.002
Takeya Kitta, Teruyuki Ogawa, Sadako Kuno, Hidehiro Kakizaki, Naoki Yoshimura
{"title":"Review: Lower urinary tract dysfunction in animal models of Parkinson's disease (PD): Translational aspects for the treatment of PD patients with overactive bladder.","authors":"Takeya Kitta, Teruyuki Ogawa, Sadako Kuno, Hidehiro Kakizaki, Naoki Yoshimura","doi":"10.1016/bs.irn.2023.12.002","DOIUrl":null,"url":null,"abstract":"<p><p>Although the loss of dopaminergic neurons in the substantia nigra and consequent motor symptoms are the hallmarks of Parkinson's disease (PD), several non-motor symptoms may appear prior to these typical motor symptoms. While a variety of non-motor symptoms have emerged as the primary predictor of PD patients' quality of life, even though motor symptoms are undoubtedly distressing. According to a study, the prevalence of lower urinary tract symptoms (LUTS) varies between 27% and 64%, suggesting that PD-related lower urinary tract dysfunction may be affected by the disease stage, the presence of concomitant conditions affecting the lower urinary tract, and other autonomic dysfunctions. Animal models can serve as a platform for research into the causes of PD-related dysfunction and the evaluation of cutting-edge therapeutic approaches although the majority of animal research have been directed toward motor symptoms of PD. At present, the cause of lower urinary tract dysfunction in PD has not been fully clarified although the increasing evidence showing the multiple mechanisms underlying PD-related LUTS has emerged. In this chapter we summarize the findings of basic research in the studies of the lower urinary tract dysfunction using with different animal PD models and we try to shed light on the translational aspects for the development of future treatment modalities in PD patients with LUTS.</p>","PeriodicalId":94058,"journal":{"name":"International review of neurobiology","volume":"174 ","pages":"211-230"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International review of neurobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.irn.2023.12.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Although the loss of dopaminergic neurons in the substantia nigra and consequent motor symptoms are the hallmarks of Parkinson's disease (PD), several non-motor symptoms may appear prior to these typical motor symptoms. While a variety of non-motor symptoms have emerged as the primary predictor of PD patients' quality of life, even though motor symptoms are undoubtedly distressing. According to a study, the prevalence of lower urinary tract symptoms (LUTS) varies between 27% and 64%, suggesting that PD-related lower urinary tract dysfunction may be affected by the disease stage, the presence of concomitant conditions affecting the lower urinary tract, and other autonomic dysfunctions. Animal models can serve as a platform for research into the causes of PD-related dysfunction and the evaluation of cutting-edge therapeutic approaches although the majority of animal research have been directed toward motor symptoms of PD. At present, the cause of lower urinary tract dysfunction in PD has not been fully clarified although the increasing evidence showing the multiple mechanisms underlying PD-related LUTS has emerged. In this chapter we summarize the findings of basic research in the studies of the lower urinary tract dysfunction using with different animal PD models and we try to shed light on the translational aspects for the development of future treatment modalities in PD patients with LUTS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
回顾:帕金森病(PD)动物模型的下尿路功能障碍:治疗帕金森病膀胱过度活动症患者的转化问题。
虽然黑质中多巴胺能神经元的缺失和随之而来的运动症状是帕金森病(PD)的特征,但在出现这些典型的运动症状之前,可能会出现一些非运动症状。尽管运动症状无疑令人痛苦,但各种非运动症状已成为帕金森病患者生活质量的主要预测因素。一项研究显示,下尿路症状(LUTS)的发病率介于 27% 和 64% 之间,这表明与帕金森病相关的下尿路功能障碍可能受到疾病阶段、影响下尿路的并发症以及其他自主神经功能障碍的影响。动物模型可作为研究与帕金森病相关的功能障碍原因和评估前沿治疗方法的平台,尽管大多数动物研究都是针对帕金森病的运动症状。目前,尽管越来越多的证据显示 PD 相关下尿路功能障碍有多种机制,但 PD 下尿路功能障碍的病因尚未完全明确。在本章中,我们总结了利用不同的帕金森病动物模型研究下尿路功能障碍的基础研究结果,并试图从转化的角度阐明未来治疗帕金森病下尿路功能障碍患者的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms. Executive dysfunction and cognitive decline, a non-motor symptom of Parkinson's disease captured in animal models. Insight gained from using animal models to study pain in Parkinson's disease. Investigating affective neuropsychiatric symptoms in rodent models of Parkinson's disease. Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson's disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1